PeptaNova

Executive Summary

PeptaNova GmbH is a German biotechnology distributor founded in 2006 and headquartered in Berlin. The company specializes in the distribution of biologically active peptides, enzyme substrates, inhibitors, and related reagents, serving as the exclusive European distributor for Peptide Institute Inc. of Japan. Its core value proposition is providing rapid delivery and simplified EU-compliant invoicing to research customers. PeptaNova operates as a private company with no disclosed funding, valuation, or active pipeline, and its business model is centered on distribution rather than drug development or proprietary therapeutics. The company maintains a low profile with no reported clinical-stage assets, patent portfolio, or revenue figures. Given its limited scale and lack of research-driven growth, PeptaNova does not present significant investment or strategic interest beyond its niche distribution role.